Germline mutations in BRCA1 and BRCA2, which account for roughly 15% of hereditary breast cancer cases, compromise DNA repair mechanisms, leading to genomic instability and increased tumorigenesis [9,10,11]. The gene discussed is BRCA1; the disease is breast cancer.